Artwork

Content provided by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M". All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M" or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Dr. M’s SPA Newsletter Volume 15 Issue 7

13:52
 
Share
 

Manage episode 487249168 series 1064617
Content provided by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M". All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M" or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Let's dive into articles that have been critical to understanding type 2 diabetes and Insulin Resistance: the Ominous Octet and now the Egregious Eleven from the BMC Medicine paper and the 2009 Diabetes paper by Dr. Ralph DeFronzo. Peter Attia recently interviewed Dr. Defronzo and I am on listen #3 because it is so good and yet incredibly complicated. This piece is a compilation of that interview and reviewing Dr. DeFronzo's papers. “…all too often, the risk factors for these disorders are not addressed promptly in clinical practice, leading to irreversible pathologic progression… Traditional approaches to treatment involving sequential therapy, in which agents are added only after one has failed, contribute to clinical inertia and often prevent goal attainment, leading to adverse outcomes…. in turn contributing to increased morbidity and mortality. In contrast, early diagnosis and prompt, intensive intervention, often with initial combination therapy, leads to faster goal attainment and improved outcomes for at-risk patients.” (Handelsman et al. 2023)(Schwartz et. al. 2024) ...literature review. Enjoy, Dr. M
  continue reading

430 episodes

Artwork
iconShare
 
Manage episode 487249168 series 1064617
Content provided by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M". All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Chris Magryta, "Dr. M", Dr. Chris Magryta, and "Dr. M" or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Let's dive into articles that have been critical to understanding type 2 diabetes and Insulin Resistance: the Ominous Octet and now the Egregious Eleven from the BMC Medicine paper and the 2009 Diabetes paper by Dr. Ralph DeFronzo. Peter Attia recently interviewed Dr. Defronzo and I am on listen #3 because it is so good and yet incredibly complicated. This piece is a compilation of that interview and reviewing Dr. DeFronzo's papers. “…all too often, the risk factors for these disorders are not addressed promptly in clinical practice, leading to irreversible pathologic progression… Traditional approaches to treatment involving sequential therapy, in which agents are added only after one has failed, contribute to clinical inertia and often prevent goal attainment, leading to adverse outcomes…. in turn contributing to increased morbidity and mortality. In contrast, early diagnosis and prompt, intensive intervention, often with initial combination therapy, leads to faster goal attainment and improved outcomes for at-risk patients.” (Handelsman et al. 2023)(Schwartz et. al. 2024) ...literature review. Enjoy, Dr. M
  continue reading

430 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play